Jack W Callicutt - Net Worth and Insider Trading

Jack W Callicutt Net Worth

The estimated net worth of Jack W Callicutt is at least $10,950 dollars as of 2024-05-12. Jack W Callicutt is the CFO of Galectin Therapeutics Inc and owns about 3,614 shares of Galectin Therapeutics Inc (GALT) stock worth over $10,950. Details can be seen in Jack W Callicutt's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Jack W Callicutt has not made any transactions after 2019-05-31 and currently still holds the listed stock(s).

Transaction Summary of Jack W Callicutt

To

Jack W Callicutt Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Jack W Callicutt owns 3 companies in total, including Galectin Therapeutics Inc (GALT) , Vystar Corp (VYST) , and VIA Pharmaceuticals Inc (VIAP) .

Click here to see the complete history of Jack W Callicutt’s form 4 insider trades.

Insider Ownership Summary of Jack W Callicutt

Ticker Comapny Transaction Date Type of Owner
GALT Galectin Therapeutics Inc 2020-01-09 Chief Financial Officer
VYST Vystar Corp 2011-03-14 Chief Financial Officer
VIAP VIA Pharmaceuticals Inc 2006-05-15 VP-Finance&Admin & Chf Acct Off

Jack W Callicutt Latest Holdings Summary

Jack W Callicutt currently owns a total of 1 stock. Jack W Callicutt owns 3,614 shares of Galectin Therapeutics Inc (GALT) as of May 31, 2019, with a value of $10,950.

Latest Holdings of Jack W Callicutt

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
GALT Galectin Therapeutics Inc 2019-05-31 3,614 3.03 10,950

Holding Weightings of Jack W Callicutt


Jack W Callicutt Form 4 Trading Tracker

According to the SEC Form 4 filings, Jack W Callicutt has made a total of 1 transactions in Galectin Therapeutics Inc (GALT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Galectin Therapeutics Inc is the acquisition of 2,354 shares on May 31, 2019, which cost Jack W Callicutt around $10,075.

Insider Trading History of Jack W Callicutt

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Jack W Callicutt Trading Performance

GuruFocus tracks the stock performance after each of Jack W Callicutt's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Jack W Callicutt is 38.17%. GuruFocus also compares Jack W Callicutt's trading performance to market benchmark return within the same time period. The performance of stocks bought by Jack W Callicutt within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Jack W Callicutt's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Jack W Callicutt

Average Return

Average return per transaction

Outperforming Transactions

0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 18.16
Relative Return to S&P 500(%) 14.66

Jack W Callicutt Ownership Network

Ownership Network List of Jack W Callicutt

No Data

Ownership Network Relation of Jack W Callicutt


Jack W Callicutt Owned Company Details

What does Galectin Therapeutics Inc do?

Who are the key executives at Galectin Therapeutics Inc?

Jack W Callicutt is the Chief Financial Officer of Galectin Therapeutics Inc. Other key executives at Galectin Therapeutics Inc include 10 percent owner 10x Fund, L.p. , director & 10 percent owner Richard E Uihlein , and Chief Medical Officer Pol F Boudes .

Galectin Therapeutics Inc (GALT) Insider Trades Summary

Over the past 18 months, Jack W Callicutt made no insider transaction in Galectin Therapeutics Inc (GALT). Other recent insider transactions involving Galectin Therapeutics Inc (GALT) include a net purchase of 3,398 shares made by Kary Eldred , a net sale of 25,000 shares made by James C Czirr , and a net purchase of 2,500 shares made by Kevin D Freeman .

In summary, during the past 3 months, insiders sold 25,000 shares of Galectin Therapeutics Inc (GALT) in total and bought 4,500 shares, with a net sale of 20,500 shares. During the past 18 months, 25,000 shares of Galectin Therapeutics Inc (GALT) were sold and 7,898 shares were bought by its insiders, resulting in a net sale of 17,102 shares.

Galectin Therapeutics Inc (GALT)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Galectin Therapeutics Inc Insider Transactions

No Available Data

Jack W Callicutt Mailing Address

Above is the net worth, insider trading, and ownership report for Jack W Callicutt. You might contact Jack W Callicutt via mailing address: 75 Fifth Street Nw Ste. 313, Atlanta Ga 30308.

Discussions on Jack W Callicutt

No discussions yet.